News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
27-Jun-2005 - Cambridge Antibody Technology announced that preliminary results of a Phase I clinical trial of CAT-354, a human anti-IL13 monoclonal antibody being studied as a potential treatment for severe asthma, showed CAT-354 to be well tolerated with no safety concerns identified. The objective of the ...
25-Apr-2005 - John Wiley & Sons, Inc., announced the launch of AntiBase 2005 and AmicBase 2005, two new comprehensive database products designed for researchers and scientists in organic chemistry, biochemistry, biotechnology, and pharmaceuticals. AntiBase 2005 is a database of 31,022 natural compounds from ...
04-Apr-2005 - Alnylam Pharmaceuticals, Inc. and DowpharmaSM, a business unit of The Dow Chemical Company announced an agreement for the manufacture and supply of candidate RNAi therapeutics for Alnylam's lead development programs in age-related macular degeneration (AMD) and respiratory syncytial virus (RSV) ...
17-Mar-2005 - Allon Therapeutics Inc., The Neuro Protection Company(TM), has presented pre-clinical data that helps explain how the company's proprietary lead compound AL-108 protects brain cells from degenerative diseases. Dr. Illana Gozes, Chief Scientific Officer of Allon, said , that AL-108 was shown to ...
15-Feb-2005 - Citing patient safety concerns and scientific findings, Amgen Inc. announced that it has confirmed its previous decision to halt clinical trials of the experimental drug GDNF (Glial-cell-lined-derived neurotrophic factor). Amgen halted studies of GDNF when scientific results indicated that ...
21-Jan-2005 - Cambrex Corporation announced that its subsidiary Cambrex Bio Science Wokingham, Ltd. has signed an agreement for the purchase of conditionally immortalized cell lines, related intellectual property and equipment of Xcellsyz Limited, Newcastle Upon Tyne, United Kingdom. Cambrex Bio Science ...
18-Jan-2005 - Addex Pharmaceuticals announced that it has entered an exclusive worldwide research collaboration and licence agreement with Ortho-McNeil Pharmaceutical, Inc. to discover, develop and commercialize novel compounds modulating allosterically G-Protein Coupled Receptors for the treatment of anxiety, ...
Strategic Analysis of Biomarkers in Clinical Trials
08-Dec-2004 - Escalating costs and lengthy clinical trials are major concerns for researchers attempting to boost productivity and efficiency in the field of drug discovery. Biomarkers are emerging as the solution to these problems with their ability to reduce drug development costs and time. "The clinical ...
24-Nov-2004 - The Hungarian Gedeon Richter Limited and its wholly owned subsidiary Gedeon Richter USA, Inc. and Forest Laboratories Ireland, Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. have entered into a collaboration agreement for Richter's atypical antipsychotic RGH-188 and related ...
New Interdisciplinary Field of Human Pharmacogenomic Epidemiology to be Established
05-Oct-2004 - Philadelphia. The University of Pennsylvania School of Medicine has been awarded a major grant from the National Institutes of Health (NIH) to bring together researchers from different disciplines to study gene-drug interactions. The three-year, $595,000 award is one of 21 in the country that ...
© 1997-2024 LUMITOS AG, All rights reserved